title: Refractory warm IgM-mediated autoimmune hemolytic anemia associated with Churg-Strauss syndrome responsive to eculizumab and rituximab.
authors.affiliation: Division of Hematology, Department of Medicine, Stanford University Medical Center, Stanford, California.
authors.forename: Mark P
authors.initials: MP
authors.lastname: Chao
authors.forename: Jison
authors.initials: J
authors.lastname: Hong
authors.forename: Christian
authors.initials: C
authors.lastname: Kunder
authors.forename: Laura
authors.initials: L
authors.lastname: Lester
authors.forename: Stanley L
authors.initials: SL
authors.lastname: Schrier
authors.forename: Ravindra
authors.initials: R
authors.lastname: Majeti
mesh_terms: D000328:Adult; D000744:Anemia, Hemolytic, Autoimmune / Q000097:blood / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage / Q000627:therapeutic use*; D001323:Autoantibodies / Q000097:blood; D015267:Churg-Strauss Syndrome / Q000097:blood / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D005260:Female; D006454:Hemoglobins / Q000032:analysis; D006461:Hemolysis / Q000187:drug effects; D006801:Humans; D007075:Immunoglobulin M / Q000276:immunology*; D000069283:Rituximab; D016896:Treatment Outcome
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D058846:Antibodies, Monoclonal, Murine-Derived; D001323:Autoantibodies; D006454:Hemoglobins; D007075:Immunoglobulin M; D000069283:Rituximab; C481642:eculizumab